Esra Erdal
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Hepatology 13
- Liver physiology and pathology 13
- Oncology 12
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- Co-authors
- Neşe Atabey (17 shared papers)Zeynep Fırtına Karagonlar (8 shared papers)Şerif Şentürk (6 shared papers)Soheil Akbari (11 shared papers)Peyda Korhan (4 shared papers)Mehmet Adnan Ozturk (5 shared papers)Nuri Öztürk (4 shared papers)Sedat Karademır (4 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (4 papers)PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (2 papers)Molecular Cancer (2 papers)Molecular Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
Esra Erdal
43 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Hepatology 358
- Cancer Research 249
- Oncology 322
- Molecular Biology 768
- Cell Biology 175
Countries citing papers authored by Esra Erdal
This map shows the geographic impact of Esra Erdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Erdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Erdal more than expected).
Fields of papers citing papers by Esra Erdal
This network shows the impact of papers produced by Esra Erdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Erdal. The network helps show where Esra Erdal may publish in the future.
Co-authors
The 25 scholars most cited alongside Esra Erdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 180 | |
| 2 | 2019 | 117 | |
| 3 | 2016 | 106 | |
| 4 | 2009 | 103 | |
| 5 | 2017 | 85 | |
| 6 | 2021 | 74 | |
| 7 | 2014 | 70 | |
| 8 | 2012 | 66 | |
| 9 | 2021 | 64 | |
| 10 | 2005 | 63 | |
| 11 | 2019 | 61 | |
| 12 | 2006 | 54 | |
| 13 | 2020 | 49 | |
| 14 | 2013 | 48 | |
| 15 | 2023 | 46 | |
| 16 | 2012 | 43 | |
| 17 | 2013 | 42 | |
| 18 | 2021 | 42 | |
| 19 | 2016 | 35 | |
| 20 | 2014 | 29 |
About Esra Erdal
Esra Erdal is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Cell Biology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver physiology and pathology (13 papers), 3D Printing in Biomedical Research (5 papers), Cancer-related Molecular Pathways (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Pluripotent Stem Cells Research (4 papers), Cancer Cells and Metastasis (3 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Telomeres, Telomerase, and Senescence (3 papers). The work is most often cited by research in Hepatology (358 citations), Cancer Research (249 citations), Oncology (322 citations), Molecular Biology (768 citations) and Cell Biology (175 citations). Esra Erdal has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Neşe Atabey, Zeynep Fırtına Karagonlar, Şerif Şentürk, Soheil Akbari, Peyda Korhan, Mehmet Adnan Ozturk, Nuri Öztürk, Sedat Karademır, Özgül Sağol and Günes Özhan. Their work appears in journals such as Frontiers in Cell and Developmental Biology, PLoS ONE, Biochemical and Biophysical Research Communications, Molecular Cancer and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.